Effective January 1, 2025, a new clinical coverage policy (CCP) will provide coverage for U.S. Food & Drug Administration (FDA) approved cell and gene therapies.
Please consult CCP 1S-13 located on the NC Medicaid Program Specific Clinical Coverage webpage for detailed information regarding this new policy.
